Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products
Docket Number:FDA-2022-D-2983 Issued by: Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Oncology Center of Excellence This guidance provides recommendations to sponsors and investigators considering the...